The clock is now ticking for shareholders of DeFi Technologies. A critical deadline of January 30, 2026, has been set for a securities fraud class action lawsuit against the company. This legal challenge stems from a dramatic downward revision of the firm’s financial forecast last November, an event that severely damaged investor confidence and triggered a steep decline in the share price.
Despite the ongoing legal proceedings, the Toronto-based firm continues to execute its growth strategy. Its subsidiary, Valour, commenced trading on Brazil’s B3 exchange in December 2025, listing five new Exchange-Traded Products (ETPs). This move coincided with a leadership transition, as co-founder Johan Wattenström assumed the role of CEO following the departure of Olivier Roussy Newton.
From a fundamental perspective, the company maintains a robust cash position of $119.5 million, reported as of September 30, 2025. Its forward price-to-earnings ratio stands at a modest 6.0. Market capitalization fluctuates between approximately $350 million and $420 million, a far cry from its 52-week high. The equity currently trades around $1.08, a significant drop from its peak of $4.95.
The lawsuit, spearheaded by the law firm Kahn Swick & Foti, centers on allegations that DeFi Technologies failed to adequately inform investors about operational challenges during the period from May to November 2025. The situation came to a head with the quarterly report released on November 14, 2025.
Should investors sell immediately? Or is it worth buying DeFi Technologies?
In that report, management slashed its full-year revenue guidance nearly in half, revising it from an initial $218.6 million down to approximately $116.6 million. Company executives cited delayed arbitrage opportunities, consolidation in digital asset prices, and intensified competition from Digital Asset Treasury (DAT) firms as the primary reasons for this drastic correction.
The market’s response was immediate and severe. The stock plummeted almost 28% over two trading sessions, falling to $1.05.
A striking divergence exists between analyst sentiment and the current market valuation. While research consensus points to an average price target of $5.17 per share and maintains a buy recommendation, the prevailing share price near $1.08 reflects profound market uncertainty. The equity exhibits extreme volatility, underscored by a beta coefficient of 3.95.
The ultimate impact of the legal action will become clearer as the January 30 deadline approaches, revealing the scale of investor participation in the class action. For now, shareholders are left navigating a landscape defined by solid fundamentals, strategic expansion, and considerable legal overhang.
